Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Clinical Trials and Research Studies

Phase 3

A Randomized Double-Blind Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1

Learn More

Phase 2

A RANDOMIZED PHASE II/III OPEN-LABEL STUDY OF IPILIMUMAB AND NIVOLUMAB VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MGMT (TUMOR O-6-METHYLGUANINE DNA METHYLTRANSFERASE) UNMETHYLATED GLIOBLASTOMA

Learn More

Phase 2

GENOMICALLY-GUIDED TREATMENT TRIAL IN BRAIN METASTASES

Learn More

Phase 2

ANBL19P1: A Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Learn More